Month: <span>May 2020</span>

Home / 2020 / May
New drug formulation could treat Candida infections
Post

New drug formulation could treat Candida infections

by University of Bristol With antimicrobial resistance (AMR) increasing around the world, new research led by the University of Bristol has shown a new drug formulation could possibly be used in antifungal treatments against Candida infections. Candida albicans, a well-known yeast usually seen in the mouth, skin, gut and vagina, is reported to form biofilms...

Post

Scientists recreate DNA damage caused by toxins from smoking

CREDIT: PHIL ROBERTS Researchers from the University of York have recreated how toxins from smoking cause unique patterns of DNA damage. The discovery could help scientists better understand the cause of bladder cancer and the link to smoking. The causes of bladder cancer remain largely unknown, however smoking is seen as the main risk factor...

Study among first to explore link between antidepressants during pregnancy and child development in kindergarten
Post

Study among first to explore link between antidepressants during pregnancy and child development in kindergarten

by University of Manitoba Children whose mothers had depression and took serotonergic antidepressants during pregnancy have an increased risk of deficits in language and cognition, compared to children of mothers who had depression during pregnancy and did not take antidepressants, according to findings in a new University of Manitoba study published today in Pediatrics, the...

Clinical trial in COVID-19 patients tests anti-inflammatory drug
Post

Clinical trial in COVID-19 patients tests anti-inflammatory drug

by The Scripps Research Institute An anti-inflammatory drug developed at Scripps Research 25 years ago is now being tested as a way to prevent acute respiratory distress in patients with COVID-19, the pandemic disease caused by the novel coronavirus. The drug, a monoclonal antibody now owned by the pharmaceutical company Implicit Bioscience, is planned to...

Nanotechnology might help fight deadly ‘cytokine storm’ of COVID-19
Post

Nanotechnology might help fight deadly ‘cytokine storm’ of COVID-19

by E.j. Mundell, Healthday Reporter For many COVID-19 patients battling for their lives in the ICU, a runaway immune system response—known as a “cytokine storm”—is their primary foe. Doctors have few tools to help tame this hyperinflammatory condition, but early research is suggesting that nanotechnology might safely deliver drugs to affected tissues, quieting the storm....

Post

Radboudumc researchers publish new insights into COVID-19

Researchers at the Radboud university medical center seem to have found an essential mechanism in the disease process of COVID-19, which has so far been overlooked. If the insight is correct, it probably has important consequences for the treatment of the disease. In an international collaborative effort it is now being investigated whether the new...

Post

Arteries respond in opposite ways for males and females – pharmaceutical

CREDIT: COPYRIGHT UC REGENTS/UC DAVIS HEALTH A protein known to expand blood vessels — key to controlling conditions like high blood pressure — actually has different functions in males and females, new UC Davis Health research shows. Conducted using arterial cells from mice, the study is the first to identify sex-based distinctions in how the...